EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Unraveling the tumor immune microenvironment of lung adenocarcinoma using single-cell RNA sequencing

Lele Song iD, Yuan Gong, Erpeng Wang iD, Jianchun Huang, Yuemin Li

Therapeutic Advances in Medical Oncology · 2024-01 · 16

DOI: 10.1177/17588359231210274 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Medical Oncology, online erschienen am 10.04.2024. Verfasst von Lele Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Chinese PLA General Hospital, Beijing, P.R. China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: national key research and development program of china.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor immune microenvironment (TIME) and its indications for lung cancer patient prognosis and therapeutic response have become new hotspots in cancer research in recent years. Tumor cells, immune cells, various regulatory factors, and their interactions in the TIME have been suggested to commonly influence lung cancer development and therapeutic outcome. The heterogeneity of TIME is composed of dynamic immune-related components, including various cancer cells, immune cells, cytokine/chemokine environments, cytotoxic activity, or immunosuppressive factors. The specific composition of cell subtypes may facilitate or hamper the response to immunotherapy and influence patient prognosis. Various markers have been found to stratify the patient prognosis or predict the therapeutic outcome. In this article, we systematically reviewed the recent advancement of TIME studies in lung adenocarcinoma (LUAD) using single-cell RNA sequencing (scRNA-seq) techniques, with specific focuses on the roles of TIME in LUAD development, TIME heterogeneity, indications of TIME in patient prognosis and therapeutic response during immunotherapy and drug resistance. The main findings in TIME heterogeneity and relevant markers or models for prognosis stratification and response prediction have been summarized. We hope that this review provides an overview of TIME status in LUAD and an inspiration for future development of strategies and biomarkers in LUAD treatment.

Schlagwörter

Stichwörter der Autor:innen

LUADNSCLCRNA sequencingheterogeneitylung adenocarcinomamutationprognosissingle-cell transcriptiontumor immune microenvironment

Autor:innen und Institutionen

  • Department of Oncology, Chinese PLA General Hospital, Beijing, P.R. China.
  • Department of Gastroenterology, The Second Medical Center of the Chinese PLA General Hospital, Beijing, P.R. China.
  • The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong province, P.R. China.
  • Department of Thoracic Surgery, The First Affiliated Hospital of Kunming Medical University. No. 295, Xichang Road, Wuhua District, Kunming, Yunnan Province 650032, P.R. China.
  • Department of Oncology, Chinese PLA General Hospital. No.8, Dongdajie, Fengtai District, Beijing 100071, P.R. China.

ORCID-Profile: Lele Song, Erpeng Wang

Förderung

  • national key research and development program of china

Zitieren

APA

Song, L., Gong, Y., Wang, E., Huang, J., & Li, Y. (2024). Unraveling the tumor immune microenvironment of lung adenocarcinoma using single-cell RNA sequencing. Therapeutic Advances in Medical Oncology, 16. https://doi.org/10.1177/17588359231210274

Vancouver

Song L, Gong Y, Wang E, Huang J, Li Y. Unraveling the tumor immune microenvironment of lung adenocarcinoma using single-cell RNA sequencing. Therapeutic Advances in Medical Oncology. 2024;16. doi:10.1177/17588359231210274

BibTeX
@article{Song2024,
  author = {Song, Lele and Gong, Yuan and Wang, Erpeng and Huang, Jianchun and Li, Yuemin},
  title = {Unraveling the tumor immune microenvironment of lung adenocarcinoma using single-cell RNA sequencing},
  journal = {Therapeutic Advances in Medical Oncology},
  year = {2024},
  volume = {16},
  doi = {10.1177/17588359231210274}
}
Kostenlos starten →